<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ninety multitransfused patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were conditioned with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and given marrow transplants from HLA-identical siblings </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty patients had complement-dependent lymphocytotoxins against a panel of cells from unrelated individuals immediately before transplantation while 60 did not </plain></SENT>
<SENT sid="2" pm="."><plain>Lymphocytotoxins were more frequent among patients who had received more blood product transfusions, and these patients were more likely to be refractory to random platelet support </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-seven patients rejected the marrow transplant while 63 had sustained engraftment </plain></SENT>
<SENT sid="4" pm="."><plain>The present of pretransplant lymphocytotoxins did not correlate with graft rejection and hence does not appear to be useful as a test for identification of patients at high risk of rejection </plain></SENT>
</text></document>